United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Redx Pharma gets $9m as AstraZeneca initiates AZD5055 phase 1 trial UK-based biotech company Redx Pharma said that it has received a milestone payment of $9 million from AstraZeneca… bySrinathJanuary 3, 2022
